Syphilis in Poland in 2019.


Journal

Przeglad epidemiologiczny
ISSN: 0033-2100
Titre abrégé: Przegl Epidemiol
Pays: Poland
ID NLM: 0413725

Informations de publication

Date de publication:
2021
Historique:
entrez: 11 5 2022
pubmed: 1 1 2021
medline: 17 5 2022
Statut: ppublish

Résumé

The aim of the study was to assess the epidemiological situation of syphilis cases in Poland in 2019 in comparison to previous years. Analysis of the epidemiological situation was based on case-based data from reports of newly detected syphilis cases received from doctors and laboratories. Additionally aggregated data from MZ-56 reports on infectious diseases, infections and poisoning from 2013 to 2018 sent from Sanitary Inspections to NIPH NIH - NRI was used. Also, data about treatment patients in dermatology/venerology clinics in 2019 reported on MZ-14 forms and published in statistics bulletin on Ministry of Health on e-health system website (actually: https://e-zdrowie.gov.pl; https://cez.gov.pl) and NIPH NIH - NRI website were used. In 2019 in Poland 1,511 syphilis cases were recognized (diagnosis rate was 3.96 per 100,000), including 79 cases among non-Polish citizens. The frequency of newly detected syphilis cases increased by 5% compared to the previous year and was higher by 13% compared to the median in 2013-2017 years. The syphilis cases were most often detected in the age group between 30 and 34 (20.7%) and among men (86.9%). Most cases were recognized among men who have sex with men (42%). In 2019, the number of newly detected syphilis cases increased compared to the previous year. Preventive initiatives should be taken, especially among key population as young people, men who have sexual contact with men, and who have risky sexual behaviors. Low syphilis diagnosis rate compared to European countries and a huge difference in some regions in Poland for diagnosis rates indicate on problem with recognition and reporting. To improve the functioning of national surveillance is essential to adequate assessment of epidemiological situation.

Identifiants

pubmed: 35543572
doi: 10.32394/pe.75.58
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

613-625

Informations de copyright

© National Institute of Public Health NIH – National Research Institute.

Auteurs

Marta Niedźwiedzka-Stadnik (M)

National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance.

Magdalena Rosińska (M)

National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance.

Karolina Zakrzewska (K)

National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH